APO RESEARCH · REPORT
Nitric Oxide Therapy System
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Product & engineering
Understand the product.
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Selected research
Industry Growth & Trends
Global Nitric Oxide Therapy System Industry Growth and Trends Forecast to 2032
Market perspective
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
According to APO Research, the global Nitric Oxide Therapy System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Nitric Oxide Therapy System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nitric Oxide Therapy System market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nitric Oxide Therapy System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nitric Oxide Therapy System.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Nitric Oxide Therapy System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nitric Oxide Therapy System Market by Company
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Nitric Oxide Therapy System Segment by Type
Protable System
Fixed System
Nitric Oxide Therapy System Segment by Application
Hospitals
Homecare Settings
Others
Nitric Oxide Therapy System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitric Oxide Therapy System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitric Oxide Therapy System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitric Oxide Therapy System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Nitric Oxide Therapy System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Protable System
- Fixed System
Applications
- Hospitals
- Homecare Settings
- Others
Companies covered
- Bellerophon Therapeutics
- BOC Healthcare
- Dan Hammer Health
- EKU Elektronik GmbH
- GeNO LLC
- International Biomedical
- SLE
- Mallinckrodt Pharmaceuticals
- Praxair,
- Vapotherm
- Linde Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Nitric Oxide Therapy System Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Nitric Oxide Therapy System Market Size by Region (2021-2032)
- 1.4.1 Global Nitric Oxide Therapy System Market Size by Region (2021-2026)
- 1.4.2 Global Nitric Oxide Therapy System Market Size by Region (2027-2032)
- 1.5 Key Regions Nitric Oxide Therapy System Market Size (2021-2032)
- 1.5.1 North America Nitric Oxide Therapy System Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Nitric Oxide Therapy System Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Nitric Oxide Therapy System Market Size Growth Rate (2021-2032)
- 1.5.4 South America Nitric Oxide Therapy System Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Nitric Oxide Therapy System Market Size Growth Rate (2021-2032)
2 Nitric Oxide Therapy System Market by Type
- 2.1 Type Introduction
- 2.1.1 Protable System
- 2.1.2 Fixed System
- 2.2 Global Nitric Oxide Therapy System Market Size by Type
- 2.2.1 Global Nitric Oxide Therapy System Market Size Overview by Type (2021-2032)
- 2.2.2 Global Nitric Oxide Therapy System Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Nitric Oxide Therapy System Market Size Forecasted by Type (2027-2032)
- 2.3 Global Nitric Oxide Therapy System Market Size by Regions
- 2.3.1 North America Nitric Oxide Therapy System Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Nitric Oxide Therapy System Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Nitric Oxide Therapy System Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Nitric Oxide Therapy System Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Nitric Oxide Therapy System Market Size Breakdown by Type (2021-2026)
3 Nitric Oxide Therapy System Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Homecare Settings
- 3.1.3 Others
- 3.2 Global Nitric Oxide Therapy System Market Size by Application
- 3.2.1 Global Nitric Oxide Therapy System Market Size Overview by Application (2021-2032)
- 3.2.2 Global Nitric Oxide Therapy System Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Nitric Oxide Therapy System Market Size Forecasted by Application (2027-2032)
- 3.3 Global Nitric Oxide Therapy System Market Size by Regions
- 3.3.1 North America Nitric Oxide Therapy System Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Nitric Oxide Therapy System Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Nitric Oxide Therapy System Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Nitric Oxide Therapy System Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Nitric Oxide Therapy System Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Nitric Oxide Therapy System Industry Trends
- 4.2 Nitric Oxide Therapy System Industry Drivers
- 4.3 Nitric Oxide Therapy System Industry Opportunities and Challenges
- 4.4 Nitric Oxide Therapy System Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Nitric Oxide Therapy System Revenue (2021-2026)
- 5.2 Global Nitric Oxide Therapy System Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Nitric Oxide Therapy System Key Company Headquarters & Area Served
- 5.4 Global Nitric Oxide Therapy System Company, Product Type & Application
- 5.5 Global Nitric Oxide Therapy System Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Nitric Oxide Therapy System Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Nitric Oxide Therapy System Players Market Share by Revenue in 2025
- 5.6.3 2025 Nitric Oxide Therapy System Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Bellerophon Therapeutics
- 6.1.1 Bellerophon Therapeutics Company Information
- 6.1.2 Bellerophon Therapeutics Business Overview
- 6.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Product Portfolio
- 6.1.5 Bellerophon Therapeutics Recent Developments
- 6.2 BOC Healthcare
- 6.2.1 BOC Healthcare Company Information
- 6.2.2 BOC Healthcare Business Overview
- 6.2.3 BOC Healthcare Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 BOC Healthcare Nitric Oxide Therapy System Product Portfolio
- 6.2.5 BOC Healthcare Recent Developments
- 6.3 Dan Hammer Health
- 6.3.1 Dan Hammer Health Company Information
- 6.3.2 Dan Hammer Health Business Overview
- 6.3.3 Dan Hammer Health Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Dan Hammer Health Nitric Oxide Therapy System Product Portfolio
- 6.3.5 Dan Hammer Health Recent Developments
- 6.4 EKU Elektronik GmbH
- 6.4.1 EKU Elektronik GmbH Company Information
- 6.4.2 EKU Elektronik GmbH Business Overview
- 6.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Product Portfolio
- 6.4.5 EKU Elektronik GmbH Recent Developments
- 6.5 GeNO LLC
- 6.5.1 GeNO LLC Company Information
- 6.5.2 GeNO LLC Business Overview
- 6.5.3 GeNO LLC Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 GeNO LLC Nitric Oxide Therapy System Product Portfolio
- 6.5.5 GeNO LLC Recent Developments
- 6.6 International Biomedical
- 6.6.1 International Biomedical Company Information
- 6.6.2 International Biomedical Business Overview
- 6.6.3 International Biomedical Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 International Biomedical Nitric Oxide Therapy System Product Portfolio
- 6.6.5 International Biomedical Recent Developments
- 6.7 SLE
- 6.7.1 SLE Company Information
- 6.7.2 SLE Business Overview
- 6.7.3 SLE Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 SLE Nitric Oxide Therapy System Product Portfolio
- 6.7.5 SLE Recent Developments
- 6.8 Mallinckrodt Pharmaceuticals
- 6.8.1 Mallinckrodt Pharmaceuticals Company Information
- 6.8.2 Mallinckrodt Pharmaceuticals Business Overview
- 6.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product Portfolio
- 6.8.5 Mallinckrodt Pharmaceuticals Recent Developments
- 6.9 Praxair,
- 6.9.1 Praxair, Company Information
- 6.9.2 Praxair, Business Overview
- 6.9.3 Praxair, Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Praxair, Nitric Oxide Therapy System Product Portfolio
- 6.9.5 Praxair, Recent Developments
- 6.10 Vapotherm
- 6.10.1 Vapotherm Company Information
- 6.10.2 Vapotherm Business Overview
- 6.10.3 Vapotherm Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Vapotherm Nitric Oxide Therapy System Product Portfolio
- 6.10.5 Vapotherm Recent Developments
- 6.11 Linde Group
- 6.11.1 Linde Group Company Information
- 6.11.2 Linde Group Business Overview
- 6.11.3 Linde Group Nitric Oxide Therapy System Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Linde Group Nitric Oxide Therapy System Product Portfolio
- 6.11.5 Linde Group Recent Developments
7 North America
- 7.1 North America Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 7.3 North America Nitric Oxide Therapy System Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 8.3 Europe Nitric Oxide Therapy System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Nitric Oxide Therapy System Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 10.3 South America Nitric Oxide Therapy System Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Nitric Oxide Therapy System Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Nitric Oxide Therapy System Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst